Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals.
Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. · 2009
Read Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. by Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2756586.txt.
Introduction
Willner and co-authors performed in 2009 the first metagenomic study of DNA viral communities in human airways, comparing five people with cystic fibrosis and five without it. Airways face a constant rain of viruses and particles from air, water, and food, and which viruses persist depends on particle traits and mucosal immunity. Lung communities in health were almost unknown.
Viral diversity was low overall, averaging about one hundred seventy-five distinct genotypes, and most of it was uncharacterized. Phage communities in cystic fibrosis patients resembled each other closely, while healthy people's phages were more distinct. Fibrosis airways were dominated by a few eukaryotic viruses, and their viral gene profiles split into two metabolic states, likely reflecting different disease states.
Catalog record
| CREATOR | Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals By Dana Willner, Mike Furlan, Matthew Haynes, Robert Schmieder, Florent E Angly, Joas Silva, Sassan Tammadoni, Bahador Nosrat, Douglas Conrad, Forest Rohwer, Jeffrey A Gold Published in: PLoS ONE DOI: 10.1371/journal.pone.0007370 ABSTRACT Abstract The human respiratory tract is constantly exposed to a wide variety of viruses, microbes and inorganic particulates from environmental air, water and food. Physical characteristics of inhaled particles and airway mucosal immunity determine which viruses and microbes will persist in the airways. Here we present the first metagenomic study of DNA viral communities in the airways of diseased and non-diseased individuals. We obtained sequences from sputum DNA viral communities in 5 individuals with cystic fibrosis (CF) and 5 individuals without the disease. Overall, diversity of viruses in the airways was low, with an average richness of 175 distinct viral genotypes. The majority of viral diversity was uncharacterized. CF phage communities were highly similar to each other, whereas Non-CF individuals had more distinct phage communities, which may reflect organisms in inhaled air. CF eukaryotic viral communities were dominated by a few viruses, including human herpesviruses and retroviruses. Functional metagenomics showed that all Non-CF viromes were similar, and that CF viromes were enriched in aromatic amino acid metabolism. The CF metagenomes occupied two different metabolic states, probably reflecting different disease states. There was one outlying CF virome which was characterized by an over-representation of Guanosine-5′-triphosphate,3′-diphosphate pyrophosphatase, an enzyme involved in the bacterial stringent response. Unique environments like the CF airway can drive functional adaptations, leading to shifts in metabolic profiles. These results have important clinical implications for CF, indicating that therapeutic measures may be more effective if used to change the respiratory environment, as opposed to shifting the taxonomic composition of resident microbiota. INTRODUCTION Each day the human respiratory tract comes into contact with billions of airborne particles, including viruses, microbes and allergens [1]. Particle size and the local airway host immune response determine which inhaled viruses and particles will adhere to epithelial surfaces and persist in the airways [1], [2]. The lungs and lower respiratory tract have generally been considered sterile in the absence of respiratory disease although very little is known about the microbiota of the upper and lower airways of non-diseased individuals. Microbes and viruses, including phage, have been implicated in chronic pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis (CF) [3]–[8]. However, most of this work has been performed using standard microbial cultures and PCR-based studies, which provide an incomplete picture of the airway microbiota and little opportunity for viral discovery compared to metagenomic techniques. Metagenomics is a powerful tool for viral and microbial community characterization since nucleic acids are isolated directly from environmental samples and sequenced, requiring no culturing, cloning, or a priori knowledge of what viruses may be present. Viruses are the most numerous and diverse biological entities on Earth, and metagenomics has been used extensively to describe viral communities in marine ecosystems [9]–[12]. The first metagenomic studies of the human microbiome were of viruses in blood, feces, and the lungs, and went far to describe previously unexplored viral communities [13]–[17]. Recent metagenomic studies of the human microbiome have largely focused on microbial populations, predominantly in the gut and the surface of the skin [18]–[21]. Cystic fibrosis is an autosomal recessive genetic disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator protein (CFTR), a gated ion channel [22], [23]. CF affects paranasal sinuses as well as the lower respiratory, hepatobiliary, pancreatic and lower gastro-intestinal tracts [23]. The current median age of survival for individuals with CF is approximately 38 years. Over 80% of CF mortalities are attributable to respiratory failure from chronic bacterial infections of the lungs, most commonly caused by Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia [4], [24]. Individuals with CF have impaired mucociliary clearance (MCC) which results in airway mucus plugging [2] [25] [2]. This creates hypoxic microenvironments, forcing invasive microbial species to adapt [2]. This unique airway environment is believed to increase viral replication and susceptibility to viral infections in individuals with CF [8], [22]. Expectorated sputum provides a sample of airway secretions from the proximal airways. Sputum also contains material from the entire respiratory tract including airway mucus, cellular debris, DNA, and degraded proteins as well as microbes, their associated phage, and eukaryotic viruses [26], [27]. Here we report the first metagenomic study of airway DNA viral communities using sputum samples from both cystic fibrosis and Non-cystic fibrosis (Non-CF) individuals, including the spouse of an individual with CF and an individual with mild asthma. Viral communities from Non-CF volunteers were characterized and compared to viromes of individuals with cystic fibrosis to determine if there is a core respiratory tract virome in non-diseased individuals. Metabolic profiles inferred from metagenomic sequences were distinctly different between Non-CF and CF viromes. Our results indicate that regardless of the presence or absence of shared taxa, a core set of metabolic functions defines the non-diseased and diseased respiratory tract DNA viromes. RESULTS AND DISCUSSION Phage taxonomy reflects airway pathology In all metagenomes, the majority of sequences (>90%) were unknown when compared to the non-redundant database using BLASTn (Table S1), which is comparable to the percentage of unknown sequences in other environmental viromes [9], [12], [28]. CF viromes had more tBLASTx similarities to phage genomes overall than Non-CF viromes, and were similar to a wider range of phage (Figure 1, Table S2). The tBLASTx analysis identified a core set of 19 phage genomes which had similarities to sequences in all metagenomes (Table S3). An additional 12 genomes had significant similarities to viromes from all CF individuals but none of the Non-CF individuals. This suggests a core set of phage characteristic of the human respiratory tract, and an additional core group in CF individuals. A few phage genomes appeared to dominated the Non-CF2, Non-CF3, and Non-CF5 viromes when tBLASTx similarities to phage genomes were plotted against the Phage Proteomic Tree (Figure 1). Over 90% of tBLASTx hits to phage in Non-CF2 were to Streptococcus phage Cp-1, and 80% of tBLASTx similaritites in Non-CF3 were attributable to two phage, Haemophilus influenza phage HP-1 and Brucella melitensis 16 M BrucI prophage. The large relative abundance of these phage may reflect their prevalence in inhaled air, since environmental air has been shown to contain diverse bacterial communities [29]. [Figure: Mapping of best tBLASTx hits to the phage proteomic tree by percentage for Non-CF (A) and CF (B) viromes.The phage genome with the highest percentage of hits (normalized to the length of the genome) is labeled for each virome.] The phage profiles of Non-CF1Asthma and Non-CF4Spouse were more similar to those of CF individuals than to other Non-CF individuals. This likeness was confirmed by PCA (Figure 2). Non-CF1Asthma and Non-CF4Spouse had values for the first and second principal components which were nearly identical to those of the CF metagenomes. The other Non-CF metagenomes had more random distribution of phage genotypes and did not appear to cluster on the PCA graph. More specifically, Non-CF2, NonCF3, and Non-CF5 all had positive values for the first principal component (0.40, 0.42, and 0.27 respectively) while all other metagenomes had negative values.